Article

Exact-power IOLs show high precision for toric refraction

Heidelberg, Germany-A method to measure the exact dioptric power of each IOL after production allows the manufacturer to include real-power labeling of the lens on a container package that lists the standard half-diopter IOL power as well as the exact power of the IOL.

Exact knowledge of the actual IOL power may be important, especially for patients undergoing refractive lens exchange procedures. A hydrophilic acrylic IOL (Easy Care 600, Technomed) with exact labeling of the IOL power seems to provide very good functional results and surpassed the already precise standard IOLs, according to Anne C. Hunold, MD, and Gerd U. Auffarth, MD, PhD.

"There are legal requirements for the production of IOLs that can range up to 1.0 D in a high-power IOL. [This IOL's manufacturer] has developed a method to measure the exact dioptric power of each lens after production and measures them in 0.1-D increments. Real-power labeling of an IOL may enhance the precision of refractive outcome," Dr. Hunold explained.

Topical anesthesia was induced followed by creation of a clear corneal incision, phacoemulsification, and implantation of the IOL.

Most IOLs that were implanted ranged in power between 18 and 24 D.

Newsletter

Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.

Related Videos
(Image credit: Ophthalmology Times) 50 years of ophthalmology: What changed the game (Part 2)
(Image credit: Ophthalmology Times) 50 years of ophthalmology: What changed the game? (Part 1)
(Image credit: Ophthalmology Times) From MIGS to gene therapy: Inder Paul Singh, MD, celebrates the past and future of glaucoma care
(Image credit: Ophthalmology Times) NeuroOp Guru: Using OCT to forecast outcomes in ethambutol optic neuropathy
(Image credit: Ophthalmology Times) Inside NYEE’s new refractive solutions center with Kira Manusis, MD
(Image credit: Ophthalmology Times) Dilsher Dhoot, MD, on the evolution of geographic atrophy therapy: where are we now?
© 2025 MJH Life Sciences

All rights reserved.